Brief: Cipher Pharmaceuticals says new drug submission for Sitavig accepted for review by Health Canada
16/02/2016 12:01
Feb 16 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO : * Says new drug submission for sitavig has been accepted for review by health Canada Source text for Eikon urn:newsml:reuters.com:*:nCNWxQdg1a Further company coverage CPH.TO ((Bengaluru Newsroom; +1 646 223 8780))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million